Elanco Animal Health Incorporated (ELAN)

USD 11.73

(-4.71%)

Operating Expenses Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual operating expenses in 2023 was 1.61 Billion USD , up 2.13% from previous year.
Elanco Animal Health Incorporated's latest quarterly operating expenses in 2024 Q2 was 443 Million USD , down -20.47% from previous quarter.
Elanco Animal Health Incorporated reported a annual operating expenses of 2.11 Billion USD in annual operating expenses 2022, down -9.19% from previous year.
Elanco Animal Health Incorporated reported a annual operating expenses of 2.32 Billion USD in annual operating expenses 2021, up 38.34% from previous year.
Elanco Animal Health Incorporated reported a quarterly operating expenses of 443 Million USD for 2024 Q2, down -20.47% from previous quarter.
Elanco Animal Health Incorporated reported a quarterly operating expenses of 570 Million USD for 2023 Q2, up 5.17% from previous quarter.

Annual Operating Expenses Chart of Elanco Animal Health Incorporated (2023 - 2015)

Historical Annual Operating Expenses of Elanco Animal Health Incorporated (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	1.61 Billion USD	2.13%
2022	2.11 Billion USD	-9.19%
2021	2.32 Billion USD	38.34%
2020	1.68 Billion USD	36.79%
2019	1.23 Billion USD	4.37%
2018	1.17 Billion USD	-5.87%
2017	1.25 Billion USD	2.57%
2016	1.22 Billion USD	-10.85%
2015	1.37 Billion USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	557 Million USD	9.43%
2024 Q2	443 Million USD	-20.47%
2023 Q2	570 Million USD	5.17%
2023 Q4	509 Million USD	-5.57%
2023 FY	2.16 Billion USD	2.13%
2023 Q3	539 Million USD	-5.44%
2023 Q1	542 Million USD	5.65%
2022 Q4	513 Million USD	1.79%
2022 FY	2.11 Billion USD	-9.19%
2022 Q3	504 Million USD	-9.68%
2022 Q2	558 Million USD	3.72%
2022 Q1	538 Million USD	-3.93%
2021 Q3	577 Million USD	-5.1%
2021 FY	2.32 Billion USD	38.34%
2021 Q4	560 Million USD	-2.95%
2021 Q1	584 Million USD	-10.22%
2021 Q2	608 Million USD	4.11%
2020 Q3	461.4 Million USD	70.13%
2020 Q4	650.5 Million USD	40.98%
2020 FY	1.68 Billion USD	36.79%
2020 Q1	300.4 Million USD	-1.38%
2020 Q2	271.2 Million USD	-9.72%
2019 Q4	304.6 Million USD	-2.65%
2019 Q3	312.9 Million USD	-1.91%
2019 Q2	319 Million USD	8.43%
2019 FY	1.23 Billion USD	4.37%
2019 Q1	294.2 Million USD	-0.71%
2018 Q4	296.3 Million USD	3.38%
2018 FY	1.17 Billion USD	-5.87%
2018 Q3	286.6 Million USD	-5.07%
2018 Q2	301.9 Million USD	2.55%
2018 Q1	294.4 Million USD	-7.71%
2017 Q1	409.7 Million USD	0.0%
2017 Q4	319 Million USD	3.5%
2017 Q2	409.7 Million USD	0.0%
2017 Q3	308.2 Million USD	-24.77%
2017 FY	1.25 Billion USD	2.57%
2016 FY	1.22 Billion USD	-10.85%
2015 FY	1.37 Billion USD	0.0%

Peer Operating Expenses Comparison of Elanco Animal Health Incorporated

Name	Operating Expenses	Operating Expenses Difference
Amneal Pharmaceuticals, Inc.	616.19 Million USD	-161.607%
Bausch Health Companies Inc.	5.23 Billion USD	69.207%
Catalent, Inc.	1.7 Billion USD	5.288%
Emergent BioSolutions Inc.	1.04 Billion USD	-54.406%
Perrigo Company plc	1.52 Billion USD	-5.463%
Teva Pharmaceutical Industries Limited	4.45 Billion USD	63.783%
Zoetis Inc.	2.76 Billion USD	41.7%